Rheumatic diseases are a group of chronic and autoimmune disorders that affect joints, muscles, and bones. According to the statistics, around 50 million American citizens have arthritis or other related rheumatic diseases.

The life quality of such patients can be significantly hampered by joint pain, stiffness, and limited mobility. However, technological advancements in research and development have led to a plethora of advanced treatments that can alleviate these symptoms and promote a better quality of life. One such leading company in this field is UCB.

What is UCB?

UCB is a multinational biopharmaceutical company that specializes in research and development of innovative treatments for various diseases, including rheumatoid arthritis, Crohn’s disease, osteoporosis, and lupus.

It was founded in Brussels, Belgium, in 1928 and operates in more than 40 countries worldwide.

: Rheumatoid Arthritis

Rheumatoid arthritis is a chronic autoimmune disorder that mainly affects joints. It leads to inflammation of the synovium, which causes the joints to swell and become painful.

UCB offers several advanced treatment options for Rheumatoid Arthritis patients, including:.

: 1) Cimzia

Cimzia is a biologic drug that inhibits TNF-alpha, which is a cytokine that triggers inflammation in the joints. When administered to Rheumatoid Arthritis patients, it helps to reduce joint pain, swelling, and stiffness.

Cimzia is administered through injection and has been proven to be effective in several clinical trials.

: 2) RoACTEMRA

RoACTEMRA is a biologic drug that targets IL-6 receptors, which are responsible for inflammation in the joints. It helps to reduce joint pain, stiffness, and swelling, and has been approved by the FDA.

RoACTEMRA is administered through injection or intravenous infusion.

: 3) Kevzara

Kevzara is a biologic drug that targets IL-6 receptors. It helps to reduce joint pain, stiffness, and swelling and has been approved by the FDA. Kevzara is administered through injection and has been proven to be effective in several clinical trials.

: 4) Vimovo

Vimovo is a non-steroidal anti-inflammatory drug (NSAID) that contains naproxen and esomeprazole. It helps to reduce inflammation and relieve joint pain and stiffness in Rheumatoid Arthritis patients.

Vimovo is administered orally and has been proven to be effective in several clinical trials.

: Crohn’s Disease

Crohn’s Disease is a chronic inflammatory disorder that affects the digestive tract. UCB offers several advanced treatment options for Crohn’s Disease patients, including:.

: 1) Cimzia

Cimzia is a biologic drug that inhibits TNF-alpha, which is a cytokine that triggers inflammation in the digestive tract. When administered to Crohn’s Disease patients, it helps to reduce inflammation and promote healing of the digestive tract.

Cimzia is administered through injection and has been proven to be effective in several clinical trials.

: 2) Entyvio

Entyvio is a biologic drug that targets the integrin molecule α4β7, which plays a role in inflammation in the digestive tract. It helps to reduce inflammation and promote healing of the digestive tract.

Entyvio is administered through intravenous infusion and has been approved by the FDA.

: Osteoporosis

Osteoporosis is a bone disease that leads to a decrease in bone density and an increased risk of fractures. UCB offers several advanced treatment options for Osteoporosis patients, including:.

: 1) Evenity

Evenity is a biologic drug that targets sclerostin, which is a protein that inhibits bone formation. It works by increasing bone formation and reducing bone resorption. Evenity is administered through injection and has been approved by the FDA.

: Lupus

Lupus is a chronic autoimmune disorder that can affect multiple organs and tissues in the body. UCB offers several advanced treatment options for Lupus patients, including:.

: 1) Cimzia

Cimzia is a biologic drug that inhibits TNF-alpha, which is a cytokine that triggers inflammation in the body. When administered to Lupus patients, it helps to reduce inflammation and alleviate symptoms such as joint pain and skin rashes.

Cimzia is administered through injection and has been proven to be effective in several clinical trials.

: 2) Rituxan

Rituxan is a biologic drug that targets B cells, which are responsible for producing antibodies that attack healthy tissues in Lupus patients. It helps to reduce inflammation and alleviate symptoms such as joint pain and skin rashes.

Rituxan is administered through intravenous infusion and has been approved by the FDA.